http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6150141-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01dc12661ed2d8a4ebb867417d1f7f9d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10
filingDate 2009-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f67e4e4b0f0ea8a341ca2166340aa84a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5fe2332ab6aa705e45fead4437132eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46ef4041c8e2266092bc92a37a85e20e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ad734ba1259028ab8c7248b89de0a86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86a6c9688e257f99c6e2588480bbcf22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7697c19360a643e9680367da709ab1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_625371897d5869a37aa31b00dc865274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b75948066c4fdc38a2aeaa53b17d0478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfc3790362fb3b1415bbd0a1690587ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b4825b521d467ed62e776c8bdd26f67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dbfbfc8e540459ffda21e93824bba6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50ba534b1395aabfdb2f959a7a3d82e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd3faeffd3be3323f23b4fc5ca53da37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e61cea458f5a1afbf2b789ae7669c134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e3945c0e465a888e94eb2100910c16e
publicationDate 2010-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-6150141-A2
titleOfInvention COMPOUNDS AND METHODS TO INHIBIT THE INTERACTION OF BCL PROTEINS WITH BINDING AGENTS
abstract 1. A compound of the formula 1: or a pharmaceutically acceptable salt thereof; where, regardless of each event, m is 0, 1, 2 or 3; n, o and p are independently of each event 1, 2, 3, 4 or 5; R1 is -OH, OC (O) R6, -OC (O) N (R6) (R7), or -N (R6) (R7); R2 is -OH, -N (R8) (R9), -N (R) C (O) N (R8) (R9), or -N (R) C (O) R10; or has the formula 1b; R3 is alkyl, halide, alkoxy, (cycloalkyl) alkoxy, arylalkyl, or -O (CH2) 2-N (R15) (R16); R4 is alkyl, alkoxy, hydroxyalkyl, alkoxyalkyl, halide, nitro , amino, acyl, amido, acyloamino, aminoalkyl, acyloaminoalkyl, acyloaminoalkylamino, sulfonylaminoalkylamino, carboxylate, or -N = C (N (R) 2) 2; R5 is -OH or -N (R17) (R18); R6 and R7 are independent of each event H, alkyl, arylalkyl, heteroaryloalkyl, or - [C (R15) (R16)] n-R19; R8 and R9 are independent of each event H, alkyl, arylalkyl or heteroarylalkyl; R10 is alkyl, haloalkyl or - [C (R15) (R16)] or -COOR; R, R11, R12, R13, R14, R15, and R16, are independent of each H or alkyl event; R17 and R18 are independent of each event H, alkyl, arylalkyl, heteroarylalkyl, alkoxy or - [C (R19) (R20)} p-R21; R19 and R20 are independent of each event H, hydroxy, alkyl, alkoxy, amino, aminoalkyl, acyloamino, sulfonyloamino, aryl, arylalkyl, cycloalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heteroarylalkyl; R21 is independent of each event H, alkyl, aryl, heteroaryl, heterocyclyl, heterocyclylalkyl, alkoxy, alkylsulfonyl, arylsulfonyl, alkylsulfonamide, arylsulfonamide, amino, amide or carboxyl; R22 independent of each event is halide or alkyl; R23 is selected from a group consisting of alkyl, hydroxyalkyl, alkoxyalkyl, acyloxyalkyl and haloalkyl; R24 is selected from a group consisting of alkyl, hydroxyalkyl, alkoxyalkyl, acyloxyalkyl and haloalkyl; and R25 is selected from a group consisting of alkyl, hydroxyalkyl, alkoxyalkyl, acyloxyalkyl and haloalkyl.
priorityDate 2006-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578879

Total number of triples: 49.